NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
23/03/2026
Voltar para busca
Dado oficial do USPTO
SUPRAPRP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SUPRAPRP
ST13
US500000087269712Classe
5, 10, 35, 41, 44
Pedido
87269712
Registro
5984748
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
24/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 41, 44
Data de depósito
15/12/2016
Data de registro
11/02/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2026
Última transação
24/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
27/04/2015
Primeiro uso no comércio
27/04/2015
Código do desenho
4
Tipo de titular
16
Localização do titular
Boynton Beach, FL, US
Examinador
CIURPITA, DREW PETER FISHER
Localização atual
Historical data usage
Titulares e representantes
Titulares
ADVANCED NEUROREGENERATIVE THERAPIES, LLC
ADVANCED NEUROREGENERATIVE THERAPIES, LLC
Representantes
Susan N. Acquista, Esq. DLA Piper LLP (US)
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical preparationssolutions containing platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations containin addition to plateletsmesenchymal and other stem and progenitor cellsfor use oninunder tissuebone and organs for the purpose of promoting cellular regenerationtissue adhesionwound healingbone and periodontum growth and boneorgan or tissue regeneration
Classe 10
Kits comprising at least one receptacle for receipt and separation of blood components from each other used to prepare platelet rich plasmaderived from donors pre-treated with g-csfsuch that said platelet rich plasma features mesenchymal and other stem and progenitor cells in addition to platelets
Classe 35
Marketing services in the nature of marketing and business support services for physicians who provide clinical medical practice consultation services in the field of advanced regenerative technologies featuring provision of preparations or services comprising application oninunder tissuebone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations containin addition to plateletsmesenchymal and other stem and progenitor cellsfor the purpose of promoting cellular regenerationtissue adhesionwound healingbone or periodontal growth and bone organ or tissue regeneration
Classe 41
Educational servicesproviding clinical training in the field of advanced regenerative technologiestraining for physicians to perform clinical services in the field of advanced regenerative technologies; providing training to prepare and provide preparations or services comprising application oninunder tissuebone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations containin addition to plateletsmesenchymal and other stem and progenitor cellsfor the purpose of promoting cellular regenerationtissue adhesionwound healingbone or periodontal growth and bone organ or tissue regeneration
Classe 44
Medicalveterinaryhygienic and beauty care services for human beings or animalsthe preparationprovision or both in or under tissuebone or organsof platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations containin addition to plateletsmesenchymal and other stem and progenitor cellsfor the purpose of promoting cellular regenerationtissue adhesionwound healingbone or periodontal growth and bone organ or tissue regeneration
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
23/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/03/2026
E815
TEAS SECTION 8 & 15 RECEIVED
24/12/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/01/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/06/2019
GNRT
NON-FINAL ACTION E-MAILED
13/06/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
13/06/2019
DOCK
ASSIGNED TO EXAMINER
31/05/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
24/04/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/04/2019
IUAF
USE AMENDMENT FILED
12/04/2019
EISU
TEAS STATEMENT OF USE RECEIVED
12/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
30/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2018
PUBO
PUBLISHED FOR OPPOSITION
04/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/08/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
30/07/2018
ALIE
ASSIGNED TO LIE
20/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/07/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
19/06/2018
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
15/05/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/04/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/04/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
19/04/2018
GNFR
FINAL REFUSAL E-MAILED
19/04/2018
CNFR
FINAL REFUSAL WRITTEN
19/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2018
ALIE
ASSIGNED TO LIE
28/02/2018
NREV
NOTICE OF REVIVAL - E-MAILED
19/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/02/2018
PETG
PETITION TO REVIVE-GRANTED
18/02/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
18/02/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/02/2018
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
09/02/2018
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/02/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
12/07/2017
GPRA
PRIORITY ACTION E-MAILED
12/07/2017
CPRA
PRIORITY ACTION WRITTEN
12/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
31/03/2017
GNRT
NON-FINAL ACTION E-MAILED
31/03/2017
CNRT
NON-FINAL ACTION WRITTEN
31/03/2017
DOCK
ASSIGNED TO EXAMINER
17/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/12/2016
NWAP
NEW APPLICATION ENTERED
19/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SUPRAPRP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.